SEMTSI 2017

X National Congress of Tropical Medicine and International Health

October 23-25, 2017
Bilbao, Spain
Representatives from DNDi and GARDP took part in the event.

ECTMIH 2017

October 16-20, 2017
Antwerp, Belgium
DNDi presented on sleeping sickness, visceral leishmaniasis, mycetoma, and onchocerciasis.

Daiichi Sankyo announces collaborative research on drugs for neglected diseases

[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.

IMTechCon 2017

October 4-6, 2017
Chandigarh, India
Graeme Bilbe, R&D Director, DNDi and Suman Rijal, Director of DNDi Regional Office India took part in the event.

ReAct

Action on Antibiotic Resistance (ReAct) Africa Annual Conference 2017

September 18-19, 2017
Machakos, Kenya
DNDi Africa’s Director, Monique Wasunna, gave a presentation on DNDi‘s various programme models.

Gordon Research Conference

66th Gordon Research Conference on Natural Products and Bioactive Compounds

July 30, 2017
New Hampshire, USA
Benjamin Perry, Open Innovations Senior Manager, Discovery, DNDi presented at the event.